Avantor Investor Day Presentation Deck

3. BIOPRODUCTION Rapid evolution of new platforms Avantor well positioned to gain market share throughout the workflow 1800s ASPIRIN Small Molecule Navantor™ 1920s INSULIN Biologics 1990s MONOCLONAL ANTIBODIES (mAbs) 2000s VIRAL VECTORS 2010s CELL THERAPY Viral Vector / Cell & Gene therapy 2020s mRNA Bioengineered → 28

View entire presentation